Verseon Presents New Data on its Precision Oral Anticoagulants at BIO International Convention



Verseon

presented new preclinical data on its novel class of precision oral

anticoagulants (PROACs) at last week’s BIO

International Convention in Boston. Verseon’s PROACs demonstrate a

unique combination of efficacy with lower......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Monday, 11 June
Share |